Antidote Technologies

Antidote Technologies addresses a critical bottleneck in clinical development: patient recruitment delays, which affect over 80% of trials. The company provides precision recruitment services to pharmaceutical sponsors and CROs while offering a free, user-friendly search tool for patients to find relevant trials. Its core value proposition lies in leveraging technology and a partner network to improve trial matching efficiency, thereby aiming to reduce delays, lower costs for sponsors, and improve patient access to novel therapies. As a private, revenue-generating services company, Antidote operates in the high-growth digital health and clinical trial enablement sector.

AI-powered clinical trial matching engine (Antidote Match) combined with a digital media network for patient recruitment and pre-screening.

The market includes large, integrated Contract Research Organizations (CROs) with digital units, standalone digital patient recruitment and matching platforms, and patient advocacy/social network communities. Antidote competes on the sophistication of its matching technology, the scale of its patient community, and its ability to deliver measurable recruitment results for sponsors.